BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 31210160)

  • 1. Detection of Anti-Phenolic Glycolipid-I antibody in sera from tuberculosis patients in Bandung, West Java, Indonesia.
    Gunawan H; Roslina N; Agusni JH; Kulsum ID; Makarti K; Hindritiani R; Suwarsa O
    Int J Mycobacteriol; 2019; 8(2):166-169. PubMed ID: 31210160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequential monitoring of leprosy patients with serum antibody levels to phenolic glycolipid-I, a synthetic analog of phenolic glycolipid-I, and mycobacterial lipoarabinomannan.
    Meeker HC; Schuller-Levis G; Fusco F; Giardina-Becket MA; Sersen E; Levis WR
    Int J Lepr Other Mycobact Dis; 1990 Sep; 58(3):503-11. PubMed ID: 2205685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Armadillo IgG and IgM antibody responses to phenolic glycolipid-I during experimental infection with M. leprae.
    Vadiee AR; Shannon EJ; Gillis TP; Mshana RN; Hastings RC
    Int J Lepr Other Mycobact Dis; 1988 Sep; 56(3):422-7. PubMed ID: 3047283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The serological response to the phenolic glycolipid of Mycobacterium leprae in Australian and Nepali leprosy patients.
    Britton WJ; Garsia RJ; Basten A
    Aust N Z J Med; 1987 Dec; 17(6):568-73. PubMed ID: 3328975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can anti-PGL-1 and anti-NDO-LID-1 antibody titers be used to predict the risk of reactions in leprosy patients?
    Devides AC; Rosa PS; de Faria Fernandes Belone A; Coelho NMB; Ura S; Silva EA
    Diagn Microbiol Infect Dis; 2018 Jul; 91(3):260-265. PubMed ID: 29669693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serodiagnosis of leprosy: relationships between antibodies to Mycobacterium leprae phenolic glycolipid I and protein antigens.
    Levis WR; Meeker HC; Schuller-Levis GB; Gillis TP; Marino LJ; Zabriskie J
    J Clin Microbiol; 1986 Dec; 24(6):917-21. PubMed ID: 3537003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of anti-PGL-I as a prognostic marker of leprosy reaction.
    Stefani MM; Martelli CM; Morais-Neto OL; Martelli P; Costa MB; de Andrade AL
    Int J Lepr Other Mycobact Dis; 1998 Sep; 66(3):356-64. PubMed ID: 9934362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating immune complexes in leprosy sera: demonstration of antibodies against mycobacterial glycolipidic antigens in isolated immune complexes.
    Yamashita JT; Cruaud P; Papa F; Rotta O; David HL
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):44-50. PubMed ID: 8326180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody response to recombinant 65-kDa, 70-kDa and 18-kDa mycobacterial antigens in leprosy patients and healthy contacts in a leprosy-endemic population.
    Ilangumaran S; Shankernarayan N; Ramu G; Muthukkaruppan V
    Int J Lepr Other Mycobact Dis; 1994 Jun; 62(2):245-55. PubMed ID: 7519226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody responses to the 18-kDa protein of Mycobacterium leprae in leprosy and tuberculosis patients.
    Roche PW; Prestidge RL; Watson JD; Britton WJ
    Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):201-7. PubMed ID: 1381739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal assessment of anti-PGL-I serology in contacts of leprosy patients in Bangladesh.
    Richardus RA; van der Zwet K; van Hooij A; Wilson L; Oskam L; Faber R; van den Eeden SJF; Pahan D; Alam K; Richardus JH; Geluk A
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006083. PubMed ID: 29228004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serological response in leprosy and tuberculosis patients to the 18-kDa antigen of Mycobacterium leprae and antigen 85B of Mycobacterium bovis BCG.
    Vikerfors T; Olcén P; Wiker H; Watson JD
    Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):571-80. PubMed ID: 8151188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serological activity of a characteristic phenolic glycolipid from Mycobacterium leprae in sera from patients with leprosy and tuberculosis.
    Brett SJ; Draper P; Payne SN; Rees RJ
    Clin Exp Immunol; 1983 May; 52(2):271-9. PubMed ID: 6407793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serologic responses to Mycobacterium leprae-specific phenolic glycolipid-I antigen in sooty mangabey monkeys with experimental leprosy.
    Gormus BJ; Ohashi DK; Ohkawa S; Walsh GP; Meyers WM; Brennan PJ; Trygg C
    Int J Lepr Other Mycobact Dis; 1988 Dec; 56(4):537-45. PubMed ID: 2464657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serological evidence of Toxoplasma gondii infection as potential risk for the development of lepromatous leprosy in an endemic area for both neglected tropical diseases in Brazil.
    Oliveira LRP; Martins LM; Souza RDC; Scheidegger de Castro Y; Nascimento LS; da Silva JA; Nahn Junior EP; da Silva WD; Peixoto-Rangel AL
    Infect Dis Poverty; 2020 Feb; 9(1):19. PubMed ID: 32051036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A simple dipstick assay for the detection of antibodies to phenolic glycolipid-I of Mycobacterium leprae.
    Bührer SS; Smits HL; Gussenhoven GC; van Ingen CW; Klatser PR
    Am J Trop Med Hyg; 1998 Feb; 58(2):133-6. PubMed ID: 9502593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of PGL-I seropositivity on the protective effect of BCG vaccination among leprosy contacts: a cohort study.
    Düppre NC; Camacho LA; Sales AM; Illarramendi X; Nery JA; Sampaio EP; Sarno EN; Bührer-Sékula S
    PLoS Negl Trop Dis; 2012; 6(6):e1711. PubMed ID: 22724040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgM antibodies to native phenolic glycolipid-I in contacts of leprosy patients in Venezuela: epidemiological observations and a prospective study of the risk of leprosy.
    Ulrich M; Smith PG; Sampson C; Zuniga M; Centeno M; Garcia V; Manrique X; Salgado A; Convit J
    Int J Lepr Other Mycobact Dis; 1991 Sep; 59(3):405-15. PubMed ID: 1890364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological response to homologous and heterologous phenolic glycolipid antigens in tuberculosis and leprosy.
    Torgal-Garcia J; Papa F; David HL
    Acta Leprol; 1989; 7 Suppl 1():102-6. PubMed ID: 2503962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seropositivity to anti-phenolic glycolipid-I in leprosy cases, contacts and no known contacts of leprosy in an endemic and a non-endemic area in northeast Brazil.
    Frota CC; Freitas MV; Foss NT; Lima LN; Rodrigues LC; Barreto ML; Kerr LR
    Trans R Soc Trop Med Hyg; 2010 Jul; 104(7):490-5. PubMed ID: 20447668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.